Live Oak Private Wealth’s abrdn Life Sciences Investors HQL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $169K | Hold |
13,223
| – | – | 0.03% | 185 |
|
|
2025
Q1 | $168K | Hold |
13,223
| – | – | 0.03% | 181 |
|
|
2024
Q4 | $173K | Hold |
13,223
| – | – | 0.03% | 176 |
|
|
2024
Q3 | $199K | Sell |
13,223
-1,196
| -8% | -$18K | 0.03% | 171 |
|
|
2024
Q2 | $204K | Buy |
14,419
+41
| +0.3% | +$581 | 0.04% | 162 |
|
|
2024
Q1 | $196K | Buy |
14,378
+57
| +0.4% | +$777 | 0.03% | 160 |
|
|
2023
Q4 | $193K | Hold |
14,321
| – | – | 0.04% | 159 |
|
|
2023
Q3 | $179K | Buy |
14,321
+28
| +0.2% | +$349 | 0.04% | 150 |
|
|
2023
Q2 | $194K | Buy |
14,293
+24
| +0.2% | +$325 | 0.04% | 156 |
|
|
2023
Q1 | $199K | Buy |
14,269
+25
| +0.2% | +$348 | 0.04% | 154 |
|
|
2022
Q4 | $202K | Buy |
14,244
+1,021
| +8% | +$14.5K | 0.04% | 161 |
|
|
2022
Q3 | $181K | Hold |
13,223
| – | – | 0.04% | 165 |
|
|
2022
Q2 | $188K | Hold |
13,223
| – | – | 0.04% | 167 |
|
|
2022
Q1 | $219K | Hold |
13,223
| – | – | 0.04% | 159 |
|
|
2021
Q4 | $254K | Hold |
13,223
| – | – | 0.05% | 162 |
|
|
2021
Q3 | $275K | Hold |
13,223
| – | – | 0.06% | 153 |
|
|
2021
Q2 | $284K | Hold |
13,223
| – | – | 0.06% | 140 |
|
|
2021
Q1 | $261K | Hold |
13,223
| – | – | 0.06% | 137 |
|
|
2020
Q4 | $261K | Hold |
13,223
| – | – | 0.07% | 128 |
|
|
2020
Q3 | $232K | Hold |
13,223
| – | – | 0.08% | 120 |
|
|
2020
Q2 | $237K | Buy |
+13,223
| New | +$237K | 0.09% | 118 |
|